MAM
DOVA

Meeder Asset Management’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Meeder Asset Management’s Portfolio DOVA Stock Details DOVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-988
Closed -$27K – 2539
2019
Q3 		$27K Buy
988
+690
+232% +$11.2K ﹤0.01% 1215
2019
Q2 		$4K Buy
298
+7
+2% +$67 ﹤0.01% 1773
2019
Q1 		$3K Sell
291
-125
-30% -$1.01K ﹤0.01% 1529
2018
Q4 		$3K Buy
416
+345
+486% +$5.55K ﹤0.01% 1549
2018
Q3 		$1K Buy
+71
New +$1.69K ﹤0.01% 1509
2017
Q4 		– Sell
-62
Closed -$2K – 1873
2017
Q3 		$2K Buy
+62
New +$1.47K ﹤0.01% 1510

Meeder Asset Management's DOVA Position: Q4 2019 in Review

Meeder Asset Management sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 988 shares — an estimated $27K sold.

Meeder Asset Management first reported a position in DOVA in Q3 2017 and held it in 6 quarters. The position peaked at $27K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

  • Meeder Asset Management reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Meeder Asset Management sold 988 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $27K.
  • Meeder Asset Management first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 6 quarters.
  • Meeder Asset Management's Dova Pharmaceuticals, Inc. Common Stock position peaked at $27K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Meeder Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.